OSE Immunotherapeutics Stock
Stocks
OSE
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 15:59:59 | |||
| 3.142 EUR | +1.95% |
|
3.131 | -0.35% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 73.9M 84.57M 67.86M 63.28M 120M 8.05B 122M 817M 317M 3.95B 318M 311M 13.61B | P/E 2026 * |
-2.37x | P/E 2027 * | -2.72x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 130M 104M 97.44M 185M 12.4B 188M 1.26B 488M 6.08B 489M 478M 20.95B | EV / Sales 2026 * |
18.2x | EV / Sales 2027 * | 12.9x |
| Free-Float |
74.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | +1.95% | ||
| 1 week | -2.12% | ||
| Current month | +0.83% | ||
| 1 month | -24.80% | ||
| 3 months | -3.97% | ||
| 6 months | -38.99% | ||
| Current year | -38.99% |
| 1 week | 3.03 |  | 3.22 |
| 1 month | 3.03 | | 4.58 |
| Current year | 2.87 | | 5.9 |
| 1 year | 2.87 | | 7.7 |
| 3 years | 2.7 | | 11.58 |
| 5 years | 2.7 | | 13.68 |
| 10 years | 2.7 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 2025-10-01 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 2025-08-19 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 2016-05-30 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 2017-06-13 |
| Director/Board Member | - | 2023-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-11-12 | Sell | Director | 30,000 | 0.1375% | ||
| 24-11-11 | Sell | Chief Administrative Officer | 10,000 | 0.0458% | ||
| 24-06-20 | Fiscal year | Director | 10,000 | 0.0459% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | -2.12% | -40.72% | -4.79% | 82.56M | |
| +0.36% | +6.85% | +0.11% | +5.85% | 48.62B | |
| -0.75% | +5.17% | +403.83% | +598.38% | 39.86B | |
| +2.93% | +11.07% | +25.76% | -6.34% | 33.91B | |
| +1.55% | +7.26% | +20.88% | +63.31% | 32.32B | |
| +1.20% | +2.26% | +15.60% | +32.43% | 24.73B | |
| +34.25% | +3.97% | - | - | 16.63B | |
| +2.77% | +6.64% | +70.07% | +131.97% | 15.52B | |
| +0.99% | +3.16% | +13.75% | +18.88% | 13.63B | |
| -2.14% | +7.08% | +14.28% | -29.08% | 13.41B | |
| Average | +0.96% | +6.51% | +58.17% | +90.07% | 23.87B | |
| Weighted average by Cap. | +0.83% | +7.72% | +87.81% | +129.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.25M 7.15M 5.74M 5.35M 10.15M 681M 10.32M 69.1M 26.78M 334M 26.86M 26.27M 1.15B | 10.53M 12.05M 9.67M 9.02M 17.09M 1.15B 17.38M 116M 45.12M 563M 45.25M 44.27M 1.94B |
| Net income | -30.59M -35M -28.09M -26.19M -49.65M -3.33B -50.49M -338M -131M -1.63B -131M -129M -5.63B | -21.47M -24.57M -19.71M -18.38M -34.85M -2.34B -35.44M -237M -91.98M -1.15B -92.25M -90.24M -3.95B |
| Net Debt | 39.88M 45.64M 36.62M 34.15M 64.75M 4.35B 65.84M 441M 171M 2.13B 171M 168M 7.34B | 62.23M 71.22M 57.14M 53.29M 101M 6.78B 103M 688M 267M 3.33B 267M 262M 11.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | €3.142 | +1.95% | 144,335 |
| 26-07-01 | €3.082 | -1.09% | 87,380 |
| 26-06-30 | €3.116 | +0.52% | 130,920 |
| 26-06-29 | €3.100 | -1.46% | 117,725 |
| 26-06-26 | €3.146 | +3.15% | 165,432 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
Select your edition
All financial news and data tailored to specific country editions
